awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38719570-1E359F9B-0F42-46A1-BB6C-4C2CA7970395
Q38719570-1E359F9B-0F42-46A1-BB6C-4C2CA7970395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38719570-1E359F9B-0F42-46A1-BB6C-4C2CA7970395
How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.
P2860
Q38719570-1E359F9B-0F42-46A1-BB6C-4C2CA7970395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38719570-1E359F9B-0F42-46A1-BB6C-4C2CA7970395
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e2b5d3bb018224f1f158e8ca806a8d87e4b84d4
P2860
Vedolizumab as induction and maintenance therapy for ulcerative colitis.